Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Cardiofaciocutaneous syndrome 2, 615278; CFC2 (Cardiofaciocutaneous syndrome) (Prenatal) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Cardiofaciocutaneous syndrome 2, 615278; CFC2 (Cardiofaciocutaneous syndrome) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Cardiomyopathy and Arrhythmia Panel Mayo Clinic Laboratories Mayo Clinic United States | 73 | 105 |
|
Comprehensive Cardiomyopathy Panel Mayo Clinic Laboratories Mayo Clinic United States | 68 | 83 |
|
Congenital Heart Disease Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 22 | 44 |
|
Hypertrophic Cardiomyopathy Panel Mayo Clinic Laboratories Mayo Clinic United States | 44 | 48 |
|
Noonan Syndrome and Related Panel Mayo Clinic Laboratories Mayo Clinic United States | 15 | 20 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Health in Code Spain | 26 | 12 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae RASopathies and Noonan Spectrum Disorders Panel Invitae United States | 60 | 28 |
|
Invitae Neurodevelopmental Disorders Panel Invitae United States | 404 | 241 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.